Aktiesnakken — Februar 2010
-
In contrast to the detailed purchase price information in table 1, our information on
the rebate component of hospitals? acquisition costs -
is limited. Nearly 60 percent of
our sample hospitals reported receiving one or more rebates. -
For some
hospitals, these rebates were as high as 29 percent of the drug?s purchase price -
så det er nok den øvre grænser for rabat?
-
Averaged over all hospitals, rebates for this drug relative to its purchase price were
likely to be considerably smaller, since most hospit -
since most hospitals did not report receiving large
rebates. -
However, hospitals reported no rebates for 14 of
the 53 SCOD categories. -
jeg er sku ikke humanist!!!
-
og jeg har læst de først sider din støvle
-
jeg laver lige et indlæg...som du nu har fået mig til
-
Birgitte Erhardtsen og Linda Overgaard i studiet om Capinordic Bank http://www.business.dk/webtv/clip/91/8050
-
Den her må falde ind under Biop's patent og gi lidt ideer om tidshorisonter? http://www.invernessmedical.com/news/upload/IMI_InvestorPresentation_Jan12-2010.swf
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind